Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 4 of 4

The US Food and Drug Administration (FDA) has approved the sublingual allergy immunotherapy tablet (SLIT) Odactra for the treatment of dust mite allergy

Odactra has already been approved for allergic rhinitis and allergic asthma by the European Medicines Agency in 11 countries, but there are no plans to sell the product in the UK yet

Source  Shutterstock